Immune Cell Profiling of Peripheral Blood as Signature for Response During Checkpoint Inhibition Across Cancer Types

Despite encouraging results with immune checkpoint inhibition (ICI), a large fraction of cancer patients still does not achieve clinical benefit. Finding predictive markers in the complexity of the tumor microenvironment is a challenging task and often requires invasive procedures. In our study, we...

Descripción completa

Detalles Bibliográficos
Autores principales: Araujo B. de Lima, Vinicius, Hansen, Morten, Spanggaard, Iben, Rohrberg, Kristoffer, Reker Hadrup, Sine, Lassen, Ulrik, Svane, Inge Marie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8027233/
https://www.ncbi.nlm.nih.gov/pubmed/33842304
http://dx.doi.org/10.3389/fonc.2021.558248

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8027233/
https://www.ncbi.nlm.nih.gov/pubmed/33842304
http://dx.doi.org/10.3389/fonc.2021.558248

Ejemplares similares